Abstract:Tumor-necrosis factor related to apoptosis inducing ligand protein(TRAIL), like tumor-necrosis factor (TNF) and Fas, is a member of TNF cytokine supper family. Many researches have showed that TNF-α can reverse the resistance to some chemotherapeutic agents in cancer cell lines, and some anticancer drugs can result in up-regulations of death receptor (DR) and further lead to the enhancement of apoptosis induced by TRAIL. In order to clarify if TRAIL can reverse the resistance to cisplatin in cancer cells, the effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein (rhTRAIL) on apoptosis in human lung adenocarcinoma cell lines resistant to cisplatin (DDP) in vitro was explored.Human lung adenocarcinoma cell lines resistant to cisplatin, A549/DDP cells, were cultured in regular condition. At 24 hours after TRAIL and DDP, alone or combined, microculture tetrazolium (MTT) dye was used to evaluate the cytotoxic effects. And besides, to detect the apoptotic effects of rhTRAIL on A549/DDP cells, flow cytometry assay was used to test the apoptosis proportion, diphenylamine assay (DPA) was applied to detect the percent of DNA fragmentation and Caspase-3 chluorometric assay was performed to test the activity of Caspase-3 among these cells.A549/DDP cells were not sensitive to low-dose rhTRAIL alone. The rate of growth inhibition and the apoptotic indexes such as the apoptosis proportion, the percent of DNA fragmentation and the activity of Caspase-3, had all no significant changes with rhTRAIL concentration less than 25μg/L (P > 0.05). But treated with higher-dose rhTRAIL more than 50μg/L, the four values changed obviously: 68.6%, (27.13± 0.66)%, (37.4±2.0)% and 0.117±0.011, respectively (P < 0.05). With combination of different concentration of rhTRAIL and 3mg/L DDP, the cyto-toxic and apoptotic effect was comparatively more apparent. The combination of rhTRAIL and 3mg/L DDP presented synergistic effect on A549/DDP, 12.5μg/L concentration of rhTRAIL together with 3mg/L DDP could kill 30.4% of A549/DDP cells. Furthermore, the rate of cell apoptosis, percent of DNA fragmentation and activity of caspase-3 increased to (19.39±0.54)%,(17.3±4.1)% and 0.138±0.009, which were significantly different from those of rhTRAIL alone (P < 0.01).High-dose rhTRAIL can also induce the cells resistant to cisplatin to apoptosis, but the cytotoxic and apoptotic effects of rhTRAIL alone are weaker than those of combination of rhTRAIL and low-dose cisplatin which can augment the apoptotic effect induced by rhTRAIL. rhTRAIL is expected to be an efficient biologic drug for treatment of lung cancer resistant to chemotherapy.

Effects of 17-Demethoxy-reblastatin Combined with Cisplatin on Proliferation and Apoptosis of Triple-Negative Breast Cancer Cell Line

Resveratrol Synergizes with Cisplatin in Antineoplastic Effects Against AGS Gastric Cancer Cells by Inducing Endoplasmic Reticulum Stress‑mediated Apoptosis and G2/M Phase Arrest.

Effects of rhTIMP-3 combined with DDP on growth inhibition and apoptosis of lung cancer cell A549

Effect of Resveratrol Combined with DDP on FRH-0201 Cholangiocarcinoma Cell Line

Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro

Effects of curcumin combined with cisplatin on cell proliferation, apoptosis, migration and invasion in hepatocarcinoma HepG2 cell

Effects Of Okadaic Acid Combined With Cisplatin On The Proliferation And Apoptosis Of Human Lung Adenocarcinoma A549 Cells

Effect of Diallyl Trisulfide on Human Ovarian Cancer Skov-3/Ddp Cell Apoptosis

Effect of Tamoxifen, Methoxyprogesterone Acetate and Combined Treatment on Cellular Proliferation and Apoptosis in SKOV3/DDP Cells Via the Regulation of Vascular Endothelial Growth Factor

Effects of recombinant human tumor-necrosis factor related to apoptosis inducing ligand protein on apoptosis of human lung adenocarcinoma cell line resistant to cisplatin]

Inhibitory Effects of Trastuzumab Combined with DDP on Cell Line of Human Ovarian Cancer

Sensitization of Decitabine Combined with Paclitaxel on Proliferation Inhibition and Apoptosis Induction of Paclitaxel-resistant MCF-7 Cells

Somatostatin Enhances Growth Inhibition by Cisplatin in Gallbladder Cancer Cells Through Inducing PTEN Expression

Effects of Diallyl Trisulfide Combined with Paclitaxel on Proliferation of Human Breast Cancer Cells and Their Mechanisms of Action

Apoptosis-inducing effect of the DR5 monoclonal antibody, D-6, alone or in combination with cisplatin, on A2780 ovarian cancer cells.

Reversal Effect of Recombinant Human Endostatin on Cisplatin Resistance Line A549/DDP Human Lung Adenocarcinoma Cells

Tumoricidal activity of combining the agonistic DR5 antibody D-6 with cisplatin in C30 cisplatin-resistant ovarian cancer in vitro and in vivo.

Growth inhibition effect of peptide P110 plus cisplatin on various cancer cells and xenotransplanted tumors in mice.

EFFECT OF SOYBEAN ISOFLAVONES COMBINED WITH CISPLATIN ON PROLIFERATION AND APOPTOSIS OF A549 CELL

Lenalidomide Improvement of Cisplatin Antitumor Efficacy on Triple-Negative Breast Cancer Cells in Vitro.

Effect of Quercetin Combined with Cisplatin on the Proliferation and Apoptosis of Cervical Cancer HeLa Cells